215 related articles for article (PubMed ID: 10941333)
21. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant.
Fujiwara M; Horiguchi M; Mori S; Yokoyama K; Horiguchi H; Fukazawa M; Fujiwara H; Yano Y; Satoh H; Kamma H
Pathol Int; 2005 Jun; 55(6):353-9. PubMed ID: 15943793
[TBL] [Abstract][Full Text] [Related]
22. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
[TBL] [Abstract][Full Text] [Related]
23. Pleomorphic lobular carcinoma in pleural fluid: diagnostic pitfall for atypical mesothelial cells.
Monaco SE; Dabbs DJ; Kanbour-Shakir A
Diagn Cytopathol; 2008 Sep; 36(9):657-61. PubMed ID: 18677762
[TBL] [Abstract][Full Text] [Related]
24. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
Fadare O; Wang SA; Hileeto D
Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
[TBL] [Abstract][Full Text] [Related]
25. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
27. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
28. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
30. Gp96 and its different expression in breast carcinomas.
Hodorova I; Rybarova S; Solar P; Vecanova J; Prokopcakova L; Bohus P; Solarova Z; Mellova Y; Schmidtova K
Neoplasma; 2008; 55(1):31-5. PubMed ID: 18190237
[TBL] [Abstract][Full Text] [Related]
31. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
33. The role of E-cadherin in low-grade ductal breast tumourigenesis.
Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I
J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.
de Deus Moura R; Wludarski SC; Carvalho FM; Bacchi CE
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):1-12. PubMed ID: 22595945
[TBL] [Abstract][Full Text] [Related]
35. Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas.
Castellana B; Escuin D; Pérez-Olabarria M; Vázquez T; Muñoz J; Peiró G; Barnadas A; Lerma E
Hum Pathol; 2012 Nov; 43(11):1902-9. PubMed ID: 22542108
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
[TBL] [Abstract][Full Text] [Related]
38. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
39. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Rosa M; Mohammadi A; Masood S
Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
